Abstract
AbstractThere is still a paucity of information on how in vitro release profiles from drug-loaded contact lenses (CLs) recorded in 3D printed eye models correlate with in vivo profiles. This work aims to evaluate the release profiles of two drug-loaded CLs in a 3D in vitro eye blink model and compare the obtained results with the release in a vial and the drug levels in tear fluid previously obtained from an animal in vivo study. In vitro release in the eye model was tested at two different flow rates (5 and 10 µL/min) and a blink speed of 1 blink/10 s. Model CLs were loaded with two different drugs, hydrophilic pravastatin and hydrophobic resveratrol. The release of both drugs was more sustained and lower in the 3D eye model compared to the in vitro release in vials. Interestingly, both drugs presented similar release patterns in the eye model and in vivo, although the total amount of drugs released in the eye model was significantly lower, especially for resveratrol. Strong correlations between percentages of pravastatin released in the eye model and in vivo were found. These findings suggest that the current 3D printed eye blink model could be a useful tool to measure the release of ophthalmic drugs from medicated CLs. Nevertheless, physiological parameters such as the composition of the tear fluid and eyeball surface, tear flow rates, and temperature should be optimized in further studies.
Graphical abstract
Funder
H2020 Marie Skłodowska-Curie Actions
Ministerio de Ciencia e Innovación
Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia
Innovation and Technology Commission - Hong Kong
Natural Sciences and Engineering Research Council of Canada
European Regional Development Fund
Universidade de Santiago de Compostela
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Wichterle O. U.S. Patents. 3,660,545; 3,408,429; 3,496,254; 3,499,862.
2. https://www.jjvision.com/press-release/johnson-johnson-vision-care-receives-fda-approval-acuvuer-theravisiontm-ketotifen. Accessed Oct 2022.
3. Lanier OL, Christopher KG, Macoon RM, Yu Y, Sekar P, Chauhan A. Commercialization challenges for drug eluting contact lenses. Expert Opin Drug Deliv. 2020;17:1133–49. https://doi.org/10.1080/17425247.2020.1787983.
4. https://www.reviewofcontactlenses.com/article/material-gains-50-years-of-the-soft-contact-lens. Accessed Oct 2022.
5. Jones L, Hui A, Phan CM, Read ML, Azar D, Buch J, Ciolino JB, Naroo SA, Pall B, Romond K, Sankaridurg P, Schnider CM, Terry L, Willcox M. CLEAR - contact lens technologies of the future. Cont Lens Anterior Eye. 2021;44:398–430. https://doi.org/10.1016/j.clae.2021.02.007.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献